An individual patient data meta-analysis of wound care in patients with toxic epidermal necrolysis

被引:2
|
作者
Lee, J. S. [1 ,6 ]
Mallitt, K. [2 ,3 ]
Fischer, G. [4 ,5 ]
Saunderson, R. B. [4 ,5 ]
机构
[1] Univ Notre Dame, Darlinghurst, NSW, Australia
[2] Univ Sydney, Fac Med, Sydney Sch Publ Hlth, Camperdown, NSW, Australia
[3] UNSW Sydney, Fac Med, Sch Psychiat, Kensington, NSW, Australia
[4] Univ Sydney, Northern Clin Sch, St Leonards, NSW, Australia
[5] Royal North Shore Hosp, Dept Dermatol, St Leonards, NSW, Australia
[6] Univ Notre Dame, Sydney Campus,160 Oxford St, Darlinghurst, NSW 2010, Australia
关键词
debridement; dressing; management; S[!text type='JS']JS[!/text; TEN; toxic epidermal necrolysis; STEVENS-JOHNSON-SYNDROME; DOSE INTRAVENOUS IMMUNOGLOBULINS; BURN UNIT; LYELLS-SYNDROME; SYNDROME S[!text type='JS']JS[!/text; MANAGEMENT; MORTALITY; EXPERIENCE; SCORTEN; CYCLOSPORINE;
D O I
10.1111/ajd.14193
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Toxic epidermal necrolysis (TEN) involves extensive mucocutaneous loss, and care is supportive. The approach to wound care includes surgical debridement or using dressings while leaving the epidermis intact. Robust evidence for either approach is lacking. We compared surgical debridement to the use of dressings while leaving the epidermis in situ (referred to hereon as dressings) in adult patients with TEN. The primary outcome assessed was mortality. The secondary outcome was time to re-epithelialisation. The impact of medications was evaluated. An individual patient data (IPD) systematic review and meta-analysis was undertaken. A random effects meta-analysis and survival analysis for IPD data examined mortality, re-epithelisation time and the effect of systemic medications. The quality of evidence was rated per the Grading of Recommendations Assessment, Development and Evaluation (GRADE). PROSPERO: CRD42021266611 Fifty-four studies involving 227 patients were included in the systematic review and meta-analysis, with a GRADE from very low to moderate. There was no difference in survival in patients who had surgical debridement or dressings (univariate: p = 0.91, multivariate: p = 0.31). Patients who received dressings re-epithelialised faster than patients who underwent debridement (multivariate HR: 1.96 [1.09-3.51], p = 0.023). Intravenous immunoglobulin (univariate HR: 0.21 [0.09-0.45], p < 0.001; multivariate HR: 0.22 [0.09-0.53], p < 0.001) and cyclosporin significantly reduced mortality (univariate HR: 0.09 [0.01-0.96], p = 0.046; multivariate HR: 0.06 [0.01-0.73], p = 0.028) irrespective of the wound care. This study supports the expert consensus of the dermatology hospitalists, that wound care in patients with TEN should be supportive with the epidermis left intact and supported with dressings, which leads to faster re-epithelialisation.
引用
收藏
页码:128 / 142
页数:15
相关论文
共 50 条
  • [21] Supportive Therapy for a Patient With Toxic Epidermal Necrolysis Undergoing Plasmapheresis
    Seczynska, Bozena
    Nowak, Ilona
    Sega, Aurelia
    Kozka, Maria
    Wodkowski, Michael
    Krolikowski, Wieslaw
    Szczeklik, Wojciech
    CRITICAL CARE NURSE, 2013, 33 (04) : 26 - 38
  • [22] A meta-analysis of cyclosporine treatment for Stevens-Johnson syndrome/toxic epidermal necrolysis
    Ng, Qin Xiang
    De Deyn, Michelle Lee Zhi Qing
    Venkatanarayanan, Nandini
    Ho, Collin Yih Xian
    Yeo, Wee-Song
    JOURNAL OF INFLAMMATION RESEARCH, 2018, 11 : 135 - 142
  • [23] A retrospective analysis of infections and antibiotic treatment in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis
    Diao, Min
    Thapa, Christina
    Ran, Xin
    Ran, Yuping
    Lv, Xiaoyan
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2020, 31 (01) : 61 - 65
  • [24] Biologic TNF-α Inhibitors for Stevens-Johnson Syndrome, Toxic Epidermal Necrolysis, and TEN-SJS']JS Overlap: A Study-Level and Patient-Level Meta-Analysis
    Cao, Jiali
    Zhang, Xuan
    Xing, Xinzhu
    Fan, Jie
    DERMATOLOGY AND THERAPY, 2023, 13 (06) : 1305 - 1327
  • [25] The use of Biobrane® for wound coverage in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
    Rogers, Alan D.
    Blackport, Erin
    Cartotto, Robert
    BURNS, 2017, 43 (07) : 1464 - 1472
  • [26] Retrospective analysis of Stevens-Johnson syndrome and toxic epidermal necrolysis in 87 Japanese patients - Treatment and outcome
    Yamane, Yumiko
    Matsukura, Setsuko
    Watanabe, Yuko
    Yamaguchi, Yukie
    Nakamura, Kazuko
    Kambara, Takeshi
    Ikezawa, Zenro
    Aihara, Michiko
    ALLERGOLOGY INTERNATIONAL, 2016, 65 (01) : 74 - 81
  • [27] Performance of the SCORTEN in Taiwanese patients with Stevens-Johnson syndrome and toxic epidermal necrolysis
    Ho, Yu-Ling
    Chang, Yun-Ting
    Chu, Yu-Tseng
    Wu, Shiao-Chi
    DERMATOLOGICA SINICA, 2010, 28 (01) : 15 - 20
  • [28] Stevens Johnson syndrome and toxic epidermal necrolysis - an Australian analysis of treatment outcomes and mortality
    Tran, Alain Khoi
    Sidhu, Shireen
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2019, 30 (07) : 718 - 723
  • [29] Care in patients with epidermal necrolysis in burn units. A nursing perspective
    Lerma, V
    Macias, M.
    Toro, R.
    Moscoso, A.
    Alonso, Y.
    Hernandez, O.
    de Abajo, F. J.
    BURNS, 2018, 44 (08) : 1962 - 1972
  • [30] Intravenous immunoglobulin in the treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis: a meta-analysis with meta-regression of observational studies
    Barron, Stacy J.
    Del Vecchio, Michael T.
    Aronoff, Stephen C.
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2015, 54 (01) : 108 - 115